Search research articles
Contact Us
Filters
Showing results (61-70 of 209) with videos related to
Page
of 21
Sort By:
Journal of Hazardous Materials
|
July 9, 2025
Di-(2-ethylhexyl) phthalate (DEHP) and its metabolite promote multiple myeloma progression and bortezomib resistance
Wenxia Li, Hangjie Fu, Lijian Zhu, et al.
Experimental Hematology & Oncology
|
June 14, 2021
Whole exome sequencing reveals a novel LRBA mutation and clonal hematopoiesis in a common variable immunodeficiency patient presented with hemophagocytic lymphohistiocytosis
Yanling Ren, Feng Xiao, Fei Cheng, et al.
Annals of Hematology
|
September 22, 2023
Overcoming right heart failure through successful treatment of cardiac dominant diffuse large B-cell lymphoma: a case report
Xianbo Huang, Shasha Wang, Chen Mei, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
March 26, 2016
[Efficacy of HAA regimen in the treatment of 64 patients with refractory/relapsed acute myeloid leukemia]
Cuihua Fan, Wenjuan Yu, Wenyuan Mai, et al.
Therapeutic Advances in Hematology
|
February 11, 2026
Early-onset de novo donor-specific anti-HLA antibodies may contribute to poor graft function following haploidentical transplantation for myelodysplastic syndrome: a rare case presentation
Xianbo Huang, Xianhui Wu, Shasha Wang, et al.
Frontiers in Genetics
|
August 1, 2022
Case Report: Pathogenesis With a Rare <i>RHOA</i> A161E Mutation in a Patient With Angioimmunoblastic T-Cell Lymphoma
Lihong Cao, Hongyan Tong, Xing Liu, et al.
British Journal of Haematology
|
April 30, 2024
MN1::ETV6-positive de novo T-cell acute lymphoblastic leukaemia is sensitive to venetoclax: A case report
Xiang Zhang, Yi Zhong, Lixia Liu, et al.
Clinical and Experimental Medicine
|
March 22, 2026
Effects and molecular mechanism of inhibiting p53 signaling pathway by NSUN4 on the resistance to BCL-2 inhibitor for diffuse large B-cell lymphoma
Yuanfei Shi, Heli Wen, Tianle Cao, et al.
Leukemia & Lymphoma
|
September 27, 2014
Low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus idarubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia
Jie Jin, Jian Chen, Shanshan Suo, et al.
Hematological Oncology
|
October 31, 2022
Co-mutation landscape and clinical significance of RAS pathway related gene mutations in patients with myelodysplastic syndrome
Yanling Ren, Wei Lang, Chen Mei, et al.
Page
of 21
Search research articles
Search
Showing results (61-70 of 209) with videos related to
Sort By:
Page
of 21
Journal of Hazardous Materials
|
July 9, 2025
Di-(2-ethylhexyl) phthalate (DEHP) and its metabolite promote multiple myeloma progression and bortezomib resistance
Wenxia Li, Hangjie Fu, Lijian Zhu, et al.
Experimental Hematology & Oncology
|
June 14, 2021
Whole exome sequencing reveals a novel LRBA mutation and clonal hematopoiesis in a common variable immunodeficiency patient presented with hemophagocytic lymphohistiocytosis
Yanling Ren, Feng Xiao, Fei Cheng, et al.
Annals of Hematology
|
September 22, 2023
Overcoming right heart failure through successful treatment of cardiac dominant diffuse large B-cell lymphoma: a case report
Xianbo Huang, Shasha Wang, Chen Mei, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
March 26, 2016
[Efficacy of HAA regimen in the treatment of 64 patients with refractory/relapsed acute myeloid leukemia]
Cuihua Fan, Wenjuan Yu, Wenyuan Mai, et al.
Therapeutic Advances in Hematology
|
February 11, 2026
Early-onset de novo donor-specific anti-HLA antibodies may contribute to poor graft function following haploidentical transplantation for myelodysplastic syndrome: a rare case presentation
Xianbo Huang, Xianhui Wu, Shasha Wang, et al.
Frontiers in Genetics
|
August 1, 2022
Case Report: Pathogenesis With a Rare <i>RHOA</i> A161E Mutation in a Patient With Angioimmunoblastic T-Cell Lymphoma
Lihong Cao, Hongyan Tong, Xing Liu, et al.
British Journal of Haematology
|
April 30, 2024
MN1::ETV6-positive de novo T-cell acute lymphoblastic leukaemia is sensitive to venetoclax: A case report
Xiang Zhang, Yi Zhong, Lixia Liu, et al.
Clinical and Experimental Medicine
|
March 22, 2026
Effects and molecular mechanism of inhibiting p53 signaling pathway by NSUN4 on the resistance to BCL-2 inhibitor for diffuse large B-cell lymphoma
Yuanfei Shi, Heli Wen, Tianle Cao, et al.
Leukemia & Lymphoma
|
September 27, 2014
Low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus idarubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia
Jie Jin, Jian Chen, Shanshan Suo, et al.
Hematological Oncology
|
October 31, 2022
Co-mutation landscape and clinical significance of RAS pathway related gene mutations in patients with myelodysplastic syndrome
Yanling Ren, Wei Lang, Chen Mei, et al.
Page
of 21